✦ LIBER ✦

Higher recovery of factor VIII (FVIII) with intermediate FVIII/von Willebrand factor concentrate than with recombinant FVIII in a haemophilia A patient with an inhibitor

✍ Scribed by T. INOUE; M. SHIMA; M. TAKEYAMA; T. MATSUMOTO; K. NISHIYA; I. TANAKA; Y. SAKURAI; J. C. GIDDINGS; A. YOSHIOKA

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical experience with Optivate®, high

✍ M. MATYSIAK; H. BOBROWSKA; W. BALWIERZ; A. CHYBICKA; J. R. KOWALCZYK; R. SHAIKH- 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Factor VIII (FVIII) gene mutations in 12

✍ Y. REPESSÉ; M. SLAOUI; D. FERRANDIZ; P. GAUTIER; C. COSTA; J. M. COSTA; J. M. LA 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 682 KB

Presurgical pharmacokinetic analysis of

✍ J. DI PAOLA; S. LETHAGEN; J. GILL; P. MANNUCCI; M. MANCO-JOHNSON; J. BERNSTEIN; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 420 KB

Immune tolerance therapy utilizing facto

✍ M. A. H. KURTH; D. DIMICHELE; C. SEXAUER; J. M. SANDERS; M. TORRES; S. C. ZAPPA; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Pharmacokinetics of Optivate®, a high-pu

✍ A. DMOSZYNSKA; A. HELLMANN; T. BAGLIN; D. O’SHAUGNESSY; J. TRELINSKI; K. KULICZK 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

Measurement of von Willebrand factor-FVI

✍ O. ZHUKOV; J. POPOV; R. RAMOS; C. VAUSE; S. RUDEN; A. SFERRUZZA; J. DLOTT; M. SA 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB